Boston, MA -- (SBWIRE) -- 06/27/2013 -- GlobalData has released its pharma report, "PharmaPoint: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics - Current and Future Players". The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing RSV Market. The report identifies and analyses the key companies shaping and driving the global RSV market. The report provides insight into the competitive RSV landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData's team of industry experts.

Scope

- Investigation of current and future market competition for RSV
- Competitor assessment
- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
- Strategic assessment of the RSV sector through market impact analysis, future market scenario and company analysis

View Full Report Details and Table of Contents

Reasons to Get This Report

- Gain a high level view of the trends shaping and driving the RSV Market
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market
- What's the next big thing in the global RSV market landscape? Identify, understand and capitalize

Companies Mentioned in this Report: AstraZeneca (MedImmune), Novavax

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- PharmaPoint: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics - US Drug Forecast and Market Analysis to 2022
- Respiratory Syncytial Virus (RSV) Prophylactic - Pipeline Assessment and Market Forecasts to 2019
- Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H2 2012
- Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H1 2013
- Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H1 2012
- EpiCast Report: Pediatric Respiratory Syncytial Virus Infection and Prophylactic Populations in the US - Epidemiology Forecast to 2022
- Alnylam Pharmaceuticals, Inc (ALNY) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- Synagis (Pediatric RSV) - Forecast and Market Analysis to 2022
- PharmaPoint: Multiple Sclerosis - Current and Future Players
- PharmaPoint: Rheumatoid Arthritis - Current and Future Players